Viridian Therapeutics (NASDAQ:VRDN) priced an underwritten public offering of shares, selling a total of ~11.43M shares at $22.00 per share. The underwriters have a 30-day option to purchase an ...
RAPT Therapeutics (NASDAQ:RAPT) priced an underwritten public offering of ~8.33M shares at $30.00 per share. The underwriters have a 30-day option to purchase up to an additional 1.25M shares. All of ...
Chugai Pharma & Rani Therapeutics ink agreement to develop and commercialize oral formulation leveraging RaniPill technology: Tokyo Wednesday, October 22, 2025, 12:00 Hrs [IST] Ch ...
original posters to be presented on cell therapy, patient-reported outcomes, innovative recruitment strategies, and clinical ...
Prospectively designed for scalability and re-dosability, Immusoft's engineered B cells represent the next generation of advanced therapeutics SAN ...
Santa Cruz Sentinel on MSN
UC Santa Cruz RNA Center hosts documentary screening and panel
The UC Santa Cruz RNA Center hosted a premiere screening of “Cracking the Code: Phil Sharp and the Biotech Revolution” at the ...
Portland's SW Sixth Avenue is under repair until Oct. 23 for paving and safety upgrades, with possible weekend work.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback